mRNA/LNP Vaccine Drying

About Ziccum

Ziccum is a pre-revenue, public biotech company developing a novel, heat-free drying platform called LaminarPace for biologics and vaccines. The core technology uses mass transfer principles to create stable, particle-engineered dry powders, potentially enabling new administration routes and reducing cold chain dependencies. Despite its innovative platform, the company filed for bankruptcy in January 2025, casting significant uncertainty over its future operations and ability to secure licensing partnerships.

Therapeutic Areas

Other Vaccine Stabilization Drugs